Opinion

Video

Examining the 505(b)(2) Pathway and Implementation into EHR

A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.

1:14 505(b)(2) Pathway Introduction

6:33 Role of Pharmacists

11:48 505(b)(2) in Oncology

26:00 Medication Management

32:34 Leveraging EHR

44:24 Unmet Needs

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.